Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.
Latest in Cardiology from ACC.org
- FDA Update: Agency Approves First Oral PCSK9 Inhibitor to Treat High CholesterolThe U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, to lower LDL cholesterol in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH).
- API-CAT Analysis: Recurrent VTE Uncommon, Associated With Poor Short-Term SurvivalRecurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival among patients with cancer-associated thrombosis on extended apixaban therapy after at least six months of anticoagulation treatment, according to a post-hoc analysis of the API-CAT trial published July 13 in Circulation.
- Protein Intake and Cardiovascular Health: Separating Signal From NoiseMedia attention to protein has increased and resulted in significant scrutiny. Many individuals are unsure of how much protein to consume and whether higher intakes, like those recommended for exercise, are safe for cardiovascular health.
- ACC CardiaCast: Treatment of ASCVD Risk: From Lifestyle to Advanced TherapiesThis episode of CardiaCast will feature a discussion on the treatment of atherosclerotic cardiovascular disease (ASCVD) risk – from lifestyle to advanced therapies, led by Dr. Maya Safarova.
- ACC CardiaCast: The What, Who, When and Why of Screening of UACRIn this first episode of The Increasing Role of Urine Albumin-Creatinine Ratio (UACR) in Cardiovascular Care series, Dr. Ankeet Bhatt interviews Dr. Katherine Tuttle on UACR, its role in kidney disease, and the importance of screening.